Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × Busulfan × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 54 Leukemia 48 Myelodysplastic Syndromes 46 Lymphoma 42 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Lymphoma, Non-Hodgkin 39 Hodgkin Disease 34 Multiple Myeloma 32 Leukemia, Lymphocytic, Chronic, B-Cell 29 Lymphoma, Mantle-Cell 23 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Follicular 23 Neoplasms, Plasma Cell 21 Congenital Abnormalities 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Burkitt Lymphoma 20 Lymphoma, Large-Cell, Immunoblastic 19 Leukemia, Myeloid, Accelerated Phase 19 Blast Crisis 19 Myeloproliferative Disorders 18 Leukemia, Myeloid, Chronic-Phase 18 Primary Myelofibrosis 16 Hematologic Neoplasms 14 Graft vs Host Disease 13 Lymphoma, T-Cell, Cutaneous 12 Dendritic Cell Sarcoma, Interdigitating 12 Myelodysplastic-Myeloproliferative Diseases 11 Anemia, Refractory, with Excess of Blasts 11

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 X-Rays 4 Phantoms, Imaging 4 Specimen Handling 3 Nuclear Medicine Department, Hospital 3 Carboplatin 3 Lapatinib 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 Biopsy 2 veliparib 1 ulixertinib 1 tipifarnib 1 tazemetostat 1 selpercatinib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 palbociclib 1 olaparib 1 marizomib 1 larotrectinib 1 imetelstat 1 erdafitinib 1 dinutuximab 1 bempegaldesleukin 1 antineoplaston AS 2-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡